Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.

Authors :: Yosipovitch G
Lio PA
Rosmarin D
Serra-Baldrich E
Legat FJ
Casillas M
Pierce E
Liu Z
Sun L
Elmaraghy H
Ständer S
Source :: The British journal of dermatology [Br J Dermatol] 2024 Jan 23; Vol. 190 (2), pp. 289-291.
Publication Year :: 2024
Abstract: Competing Interests: Conflicts of interest see Appendix S1 for the full Conflicts of Interest statement.

Subjects :: Humans
Pruritus
Antibodies, Monoclonal
Sleep
Severity of Illness Index
Double-Blind Method
Treatment Outcome
Dermatitis, Atopic

Full Text Access

Tools